Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Terminated1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT05218655Phase 3Completed
A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease
Inherited Mitochondrial Disease
StudydirectorStart date: 2022-06-22
NCT04378075Phase 2/3Terminated
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Alpers DiseaseAlpers SyndromeDrug Resistant Epilepsy+5 more
StudydirectorStart date: 2020-09-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05218655Phase 3StudyDirector

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Inherited Mitochondrial Disease
Completed
NCT04378075Phase 2/3StudyDirector

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Alpers DiseaseAlpers SyndromeDrug Resistant Epilepsy+5 more
Terminated

All 2 trials loaded